Price
Financials
Standalone, Rs crore| Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Sales | 5.76 | 10.41 | 28.73 | 13.15 | 13.39 | 0.00 |
| Expenses | 5.22 | 9.36 | 27.74 | 12.67 | 12.84 | 0.16 |
| Operating Profit | 0.54 | 1.05 | 0.99 | 0.48 | 0.55 | -0.16 |
| OPM % | 9.38% | 10.09% | 3.45% | 3.65% | 4.11% | |
| Other Income | 0.00 | 0.10 | 0.02 | 0.22 | 0.00 | 0.00 |
| Interest | 0.00 | 0.05 | 0.04 | 0.04 | 0.06 | 0.04 |
| Depreciation | 0.05 | 0.20 | 0.20 | 0.28 | 0.00 | 0.00 |
| Profit before tax | 0.49 | 0.90 | 0.77 | 0.38 | 0.49 | -0.20 |
| Tax % | 20.41% | 26.67% | 0.00% | 39.47% | 0.00% | 0.00% |
| Net Profit | 0.39 | 0.65 | 0.76 | 0.23 | 0.49 | -0.20 |
| EPS in Rs | 0.38 | 0.64 | 0.75 | 0.12 | 0.26 | -0.11 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 8.24 | 7.01 | 11.28 | 16.16 | 41.88 | 2.05 | 0.00 |
| Expenses | 0.00 | 0.07 | 7.20 | 5.92 | 8.56 | 14.56 | 40.41 | 2.69 | 0.29 |
| Operating Profit | 0.00 | -0.07 | 1.04 | 1.09 | 2.72 | 1.60 | 1.47 | -0.64 | -0.29 |
| OPM % | 12.62% | 15.55% | 24.11% | 9.90% | 3.51% | -31.22% | |||
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | -1.23 | 0.10 | 0.24 | 0.01 | 0.00 |
| Interest | 0.00 | 0.00 | 0.02 | 0.01 | 0.00 | 0.06 | 0.08 | 0.13 | 0.08 |
| Depreciation | 0.00 | 0.00 | 0.01 | 0.02 | 0.04 | 0.25 | 0.48 | 0.63 | 0.45 |
| Profit before tax | 0.00 | -0.07 | 1.01 | 1.06 | 1.45 | 1.39 | 1.15 | -1.39 | -0.82 |
| Tax % | 0.00% | 23.76% | 30.19% | 25.52% | 25.18% | 13.04% | -6.47% | 0.00% | |
| Net Profit | 0.00 | -0.07 | 0.77 | 0.75 | 1.08 | 1.04 | 0.99 | -1.30 | -0.82 |
| EPS in Rs | 0.00 | -70.00 | 154.00 | 28.86 | 1.65 | 1.02 | 0.52 | -0.69 | -0.43 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | % | % | -100% | ||
| Compounded Profit Growth | % | % | % | 37% | ||
| Stock Price CAGR | % | % | -46% | -51% | ||
| Return on Equity | % | % | % | % |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.05 | 0.26 | 6.56 | 10.20 | 18.86 | 18.86 |
| Reserves | 0.00 | -0.07 | 0.70 | 6.71 | 5.85 | 14.17 | 19.49 | 19.98 |
| Borrowings | 2.13 | 2.13 | 2.21 | 1.60 | 0.21 | 3.41 | 12.15 | 12.06 |
| Other Liabilities | 0.00 | 0.07 | 6.55 | 4.55 | 0.82 | 1.18 | 41.59 | 36.76 |
| Total Liabilities | 2.14 | 2.14 | 9.51 | 13.12 | 13.44 | 28.96 | 92.09 | 87.66 |
| Fixed Assets | 0.00 | 0.00 | 0.04 | 0.02 | 0.25 | 1.08 | 1.96 | 2.16 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.08 | 0.08 | 0.08 | 0.08 | 0.00 |
| Investments | 2.13 | 2.13 | 2.13 | 2.13 | 0.01 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.01 | 0.01 | 7.34 | 10.89 | 13.10 | 27.80 | 90.05 | 85.50 |
| Total Assets | 2.14 | 2.14 | 9.51 | 13.12 | 13.44 | 28.96 | 92.09 | 87.66 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -0.01 | 0.01 | 0.53 | -5.34 | -4.80 | -12.70 | -20.60 | 3.78 | 0.38 |
| Cash from Investing Activity | -2.13 | 0.00 | -0.04 | -0.10 | 1.84 | -1.07 | -1.13 | -0.12 | 0.01 |
| Cash from Financing Activity | 2.13 | 0.00 | 0.12 | 4.85 | 2.96 | 14.07 | 21.67 | -3.84 | -0.48 |
| Net Cash Flow | 0.00 | 0.01 | 0.61 | -0.59 | 0.01 | 0.30 | -0.06 | -0.19 | -0.09 |
| Free Cash Flow | -0.01 | 0.01 | 0.49 | -5.43 | -5.07 | -13.78 | -21.73 | 3.66 | 0.38 |
| CFO/OP | -14% | 51% | -490% | -176% | -794% | -1,400% | -591% | -131% |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 218.38 | 411.86 | 136.23 | 175.95 | 100.58 | ||||
| Inventory Days | 93.31 | 54.32 | 152.91 | 163.87 | 97.82 | ||||
| Days Payable | 66.89 | 52.87 | 10.76 | 5.02 | 266.90 | ||||
| Cash Conversion Cycle | 244.81 | 413.31 | 278.37 | 334.79 | -68.50 | ||||
| Working Capital Days | 7.97 | 244.72 | 388.95 | 525.82 | 323.60 | ||||
| ROCE % | -3.33% | 40.95% | 18.56% | 26.90% | 7.18% | 2.55% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 27.12% | 19.61% | 19.61% | 19.61% | 19.61% | 19.61% | 19.61% | 19.61% | 19.61% | 19.61% | 19.61% | 19.61% |
| Public | 72.87% | 80.39% | 80.39% | 80.40% | 80.39% | 80.39% | 80.39% | 80.40% | 80.38% | 80.39% | 80.39% | 80.39% |
| No. of Shareholders | 712 | 706 | 671 | 620 | 631 | 744 | 906 | 912 | 917 | 902 | 895 | 876 |
Fundamentals
Market Cap₹ 4.45 Cr.
Current Price₹ 2.36
Book Value₹
ROCE%
ROE%
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-100%
Compounded Profit Growth (TTM)37%
Standalone figures.
Valuation
Market capRs 4 Cr
Enterprise valueRs 4 Cr
Price to sales2.17x
EV / sales2.17x
Price to cash flow1.18x
Earnings yield-29.21%
P/E, 3-year average19.19x
P/B, 3-year average0.58x
P/E, 5-year average19.19x
P/B, 5-year average0.58x
Profitability
Operating margin (excl. other income)-31.22%
Operating margin (incl. other income)-30.73%
EBITDA margin-30.73%
Pre-tax margin-67.80%
Net profit margin-63.41%
ROE, 3-year average4.41%
ROCE, 3-year average5.16%
ROA, 3-year average3.27%
ROE, 5-year average9.85%
ROCE, 5-year average10.64%
ROA, 5-year average5.33%
Tax rate6.47%
Growth
Sales growth (latest year)-95.11%
Profit growth (latest year)-231.31%
Sales CAGR, 3 years-43.36%
Sales CAGR, 5 years-24.29%
Per share
EPS (TTM)Rs -0.69
EPS, 3-year averageRs 0.77
EPS, 5-year averageRs 8.01
Sales per shareRs 1.09
Cash flow per shareRs 2.00
Free cash flow per shareRs 0.20
Efficiency
Creditor days267 days
Cash conversion cycle-68 days
Working capital days324 days
Leverage
Interest coverage-9.69x
Cash flow
Cash from Operating Activity (latest year)Rs 4 Cr
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs -4 Cr
Net Cash Flow (latest year)Rs -0 Cr
Free cash flow (latest year)Rs 0 Cr
Cash from ops / profit, 5 years-34.28x
Sales to cash flow0.54x
Statement figures
Net sales (TTM)Rs 2 Cr
Net sales (latest year)Rs 2 Cr
Operating profit excl. other income (latest year)Rs -1 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs -1 Cr
PBDT (TTM)Rs -1 Cr
Profit before tax (TTM)Rs -1 Cr
Tax (latest year)Rs -0 Cr
Net profit (TTM)Rs -1 Cr
Net profit (latest year)Rs -1 Cr
Depreciation (TTM)Rs 1 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 2 Cr
Total expenditure (latest year)Rs 3 Cr
Total income (latest year)Rs 2 Cr
Shares outstanding (crore)1.89
Ownership
Promoter holding19.61% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | 543579 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -5.6% | -2.8% | -2.8 pts |
| 3 years | -86.0% | +14.2% | -100.2 pts |
Red flags
| explain | Weak cash conversion Cash from operations was -4044% of net profit over the last 3 years |
| explain | Share dilution Share count up 0% in a year, 186% in three |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Sep 2025Sales ₹0 Cr -100.0% vs Mar 2023.
Net loss ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Godrej Consumer Products Ltd | 87,493 | 42.1 | 18.8 % |
| Dabur India Ltd | 67,481 | 34.0 | 20.3 % |
| Colgate-Palmolive (India) Ltd | 48,552 | 35.5 | 108 % |
| Cupid Ltd | 38,726 | 282 | 33.9 % |
| Gillette India Ltd | 22,694 | 34.0 | 90.7 % |
| Procter & Gamble Hygiene and Health Care Ltd | 22,305 | 28.2 | 157 % |
| Emami Ltd | 16,633 | 22.0 | 28.1 % |
| Honasa Consumer Ltd | 14,399 | 57.0 | 19.2 % |
| Bajaj Consumer Care Ltd | 6,439 | 28.9 | 30.0 % |
| Anondita Medicare Ltd | 2,085 | 62.3 | 43.8 % |
| Recode Studios Ltd | 454 | 40.5 | 74.1 % |
| Radix Industries (India) Ltd | 203 | 69.2 | 19.6 % |
| Macobs Technologies Ltd | 189 | 65.3 | 11.0 % |
| H. R. Hygiene Products Ltd | 156 | 13.7 | 30.4 % |
| Thrive Future Habitats Limited | 100 | -7.67 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Naturo Indiabull Ltd?
Naturo Indiabull Ltd (543579) has a market capitalisation of Rs 4.45 Cr. at the 2026-09-07 close.
What were Naturo Indiabull Ltd's latest quarterly results?
In the Sep 2025 quarter, Naturo Indiabull Ltd sales was Rs 0 Cr (-100.0% vs Mar 2023) with a net loss of Rs 0 Cr.